（编辑 王雪儿） 证券日报网讯 1月30日，贤丰控股发布公告称，公司预计2025年1月1日至2025年12月31日归属于上市公 司股东的净利润为1，660万元至2，480万元，比上年同期增长114.69%至121.95%。 ...

南财智讯1月30日电，贤丰控股发布2025年度业绩预告，预计2025年全年归属于上市公司股东的净利润 为1,660万元—2,480万元，同比预增114.69%—121.95%；预计2025年全年归属于上市公司股东的扣除非 经常性损益的净利润为-2,080万元—-1,400万元。报告期公司经营收入实现稳定增长，主要系覆铜板业 务板块巩固拓展，为整体业绩发展奠定了基础。公司归属于上市公司股东的净利润较上年同期实现扭亏 为盈、同比增长，主要原因为本报告期经营基本面持续改善，叠加非经常性损益正向贡献，对因业务不 达预期进行计提的资产减值损失，以及相关业务信用减值损失冲减了影响；同时，上年同期公司控股子 公司计提大额商誉减值，本期无该项。本报告期非经常性损益金额约4400万元，主要为当期处置厂房确 认收益。扣除非经常性损益后的净利润较上年同期亏损减少，主要为公司覆铜板业务增长带动主营业务 盈利能力边际改善。 ...

证券代码：002141 证券简称：贤丰控股 公告编号：2026-002 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：预计净利润为正值且属于扭亏为盈情形 （1）以区间数进行业绩预告的 单位：万元 贤丰控股股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性 陈述或重大遗漏。 | 项 目 | | 本报告期 | | | 上年同期 | | --- | --- | --- | --- | --- | --- | | 归属于上市公司 | 比上年同 | 1,660 | ～ | 2,480 | -11,300.62 | | 股东的净利润 | 期增长 | 114.69% | ～ | 121.95% | | | 扣除非经常性损 | | -2,080 | ～ | -1,400 | | | 益后的净利润 | 比上年同 期增长 | 84.16% | ～ | 89.34% | -13,130.18 | | 基本每股收益 （元/股） | | 0.0162 | ～ | 0.0242 | -0.10 ...

资金面上看，今日动物疫苗概念板块获主力资金净流出0.49亿元，其中，10股获主力资金净流出，6股 主力资金净流出超千万元，净流出资金居首的是大北农，今日主力资金净流出4489.02万元，净流出资 金居前的还有亨通股份、贤丰控股、海利生物等，主力资金分别净流出4353.33万元、1411.00万元、 1393.13万元。今日主力资金净流入居前的概念股有海正药业、金河生物、科兴制药等，主力资金分别 净流入2868.39万元、1781.93万元、1457.47万元。 动物疫苗概念资金流出榜 截至1月27日收盘，动物疫苗概念下跌2.76%，位居概念板块跌幅榜前列，板块内，东方生物、贤丰控 股、瑞普生物等跌幅居前，股价上涨的有3只，涨幅居前的有生物股份、海正药业、亨通股份等，分别 上涨2.04%、1.10%、0.50%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 培育钻石 | 3.31 | 动物疫苗 | -2.76 | | 汽车芯片 | 3.26 | 禽流感 | -2.03 | | 国家大基金持股 | 3.18 ...

证券之星消息，1月27日动物保健板块较上一交易日下跌2.78%，回盛生物领跌。当日上证指数报收于 4139.9，上涨0.18%。深证成指报收于14329.91，上涨0.09%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 002868 | *ST绿康 | 2988.76万 | 24.73% | -4066.41万 | -33.65% | 1077.65万 | 8.92% | | 600195 中牧股份 | | 2127.67万 | 5.68% | 4526.16万 | 12.07% | -6653.83万 | -17.75% | | 002688 金河生物 | | 1929.37万 | 5.73% | -1475.90万 | -4.39% | -453.46万 | -1.35% | | 300119 瑞普生物 | | 1604.24万 | 5.07% | 1360.73万 | 4.3 ...

Market Overview - The three major A-share indices opened lower on January 27, with the Shanghai Composite Index closing at 4139.9 points, up 0.18% [2] - The ChiNext Index rose by 0.71% to 3342.6 points, while the Sci-Tech 50 Index increased by 1.51% to 1555.98 points [2] Trading Activity - A total of 1928 stocks rose, while 3450 stocks fell, with 91 stocks remaining flat [3] - The total trading volume was 28.949 billion yuan, a decrease of 3.533 billion yuan from the previous trading day [3] Sector Performance - Semiconductor stocks saw significant gains, with over 20 stocks hitting the daily limit or rising more than 10% [5] - Gold stocks also performed well, with several stocks reaching the daily limit or increasing by over 10% [5] - Coal and basic metal sectors experienced notable declines, with major coal stocks dropping over 4% [6] Market Sentiment and Predictions - Financial analysts suggest that the A-share market may continue to experience fluctuations in the short term due to increased overseas uncertainties and pressure at previous high levels [7] - The current market is viewed as a short-term adjustment risk, with expectations for continued upward movement in the medium term [7] - Long-term perspectives indicate that the current market trend is still in its mid-stage, with potential for a "slow bull" market to continue [8][9] Investment Recommendations - Analysts recommend focusing on sectors such as technology, particularly AI and robotics, as well as industries benefiting from price increases like chemicals and non-ferrous metals [8][9] - Short-term investment opportunities are suggested in power equipment and photovoltaic sectors, which are supported by market demand and policies [10]

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600201 | 生物股份 | 17.35 | -1.42% | 31.57万 | 5.51亿 | | 603566 | 普莱柯 | 13.78 | -0.72% | 5.94万 | 8171.47万 | | 600195 | 中牧股份 | 8.49 | -0.59% | 14.59万 | 1.23亿 | | 002868 | *ST绿康 | 37.28 | -0.43% | 8137.0 | 3038.12万 | | 300119 | 瑞普生物 | 20.38 | -0.39% | 4.53万 | 9258.76万 | | 002141 | 贤丰控股 | 4.19 | 0.00% | 154.61万 | 6.70亿 | | 688098 | 申联生物 | 9.97 | 0.10% | 5.22万 | 5205.80万 | | 002688 | 金河生物 | 6.39 | 0.16% | 13.54万 | 8616.98万 | | 688526 | ...

Core Viewpoint - The company, Xianfeng Holdings, announced the need to replace its independent director, Mr. Deng Yanchang, due to the expiration of his six-year term as per regulations [2] Group 1: Independent Director Tenure - Mr. Deng Yanchang has served as an independent director since January 23, 2020, and his term is about to reach the six-year limit [2] - According to the "Management Measures for Independent Directors of Listed Companies," independent directors can serve a maximum of six consecutive years [2] Group 2: Replacement Process - The company is currently in the process of nominating candidates for the independent director position and related preparations [2] - The election for the new independent director will be postponed to ensure continuity and stability in the board's operations [2] Group 3: Governance and Stability - Until the new independent director is elected, Mr. Deng will continue to fulfill his responsibilities in accordance with the Company Law and relevant regulations [2] - The delay in the replacement of the independent director will not affect the normal functioning of the company's board [2]

特此公告。 贤丰控股股份有限公司 董事会 2026 年 1 月 22 日 关于延期更换选举独立董事的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 贤丰控股股份有限公司（以下简称"公司"）现任独立董事邓延昌先生自 2020 年 1 月 23 日起担任公司独立董事，连任期限即将满六年。根据《上市公司 独立董事管理办法》关于"独立董事每届任期与上市公司其他董事任期相同，任 期届满，可以连选连任，但是连续任职不得超过六年"的规定，公司需要更换选 举独立董事。 目前，公司正在依法依规开展独立董事候选人提名及相关筹备工作，鉴于公 司独立董事候选人提名等工作尚未完成，为确保公司董事会工作的连续性和稳定 性，经审慎研究决定，本次更换选举独立董事工作将适当延期。在新任独立董事 选举完成前，原独立董事邓延昌先生将继续依照《公司法》《公司章程》及相关 监管规定履行独立董事职责，确保公司治理结构平稳运行。 公司独立董事的延期更换选举不会影响公司董事会的正常运行。公司将在相 关董事提名人选确定后，尽快完成独立董事的更换选举工作并及时履行相应信息 披露义务。 证券代码：00214 ...

Core Viewpoint - The animal health sector experienced a slight increase of 0.54% on January 22, with Xianfeng Holdings leading the gains. The Shanghai Composite Index rose by 0.14% to close at 4122.58, while the Shenzhen Component Index increased by 0.5% to 14327.05 [1]. Group 1: Stock Performance - Xianfeng Holdings (002141) closed at 4.19, up 9.97% with a trading volume of 720,300 shares and a transaction value of 297 million yuan [1]. - Other notable performers include Biological Shares (600201) at 17.60, up 1.79%, and Zhongmu Shares (600195) at 8.54, also up 1.79% [1]. - The overall trading volume and transaction values for various stocks in the animal health sector indicate active market participation [1]. Group 2: Capital Flow - The animal health sector saw a net inflow of 73.79 million yuan from institutional investors, while retail investors experienced a net outflow of 27.83 million yuan [2]. - The main capital inflow was primarily directed towards Xianfeng Holdings, which attracted 121 million yuan from institutional investors, representing 40.71% of its trading volume [3]. - Other stocks like Jinhe Biological (002688) and *ST Green Health (002868) also saw varying degrees of net inflow and outflow from different investor categories [3].